Get ready for the investment opportunity of a lifetime with GPT Healthcare’s IPO! Dive into the details of this groundbreaking offering, set to revolutionize the healthcare industry. Discover why investors are buzzing about GPT Healthcare’s potential to soar to new heights.
GPT Healthcare IPO
GPT Healthcare Limited, operating a chain of mid-sized, multi-specialty hospitals in Eastern India under the brand ILS Hospitals, is set to launch its initial public offering (IPO) on February 22, 2024, as reported earlier. Let’s delve into the details of this significant financial move.
The GPT Healthcare IPO will consist of a mix of fresh shares and an offer-for-sale, with the price band set at Rs 177-186 per share. GPT Healthcare aims to raise approximately Rs 525.14 crore through the issuance of 0.22 crore fresh shares and an offer-for-sale of 2.61 crore shares. BanyanTree Growth Capital II LLC will exit the company by selling its entire shareholding of over 2.60 crore equity shares and the net proceeds from the IPO will primarily go towards the repayment or prepayment of outstanding borrowings and for general corporate purposes.
Must Read
GPT Healthcare IPO is set to be listed on both BSE and NSE, with a tentative listing date scheduled for Thursday, February 29, 2024.
Financial Performance
GPT Healthcare has demonstrated robust financial performance, with a net profit recorded at Rs 39 crore and EBITDA at Rs 80 crore for FY23. Net profit for the six months ended FY24 grew by 38.3 percent year-on-year to Rs 23.5 crore.
The company specializes in delivering integrated healthcare services with a focus on secondary and tertiary care across over 35 specialties and super-specialties.
As GPT Healthcare IPO is set to hit the stock market, investors have the opportunity to participate in a company with a strong foothold in the healthcare sector of Eastern India. While the company has demonstrated impressive financial performance, potential investors should carefully consider the associated risks before making investment decisions.
Bhaarat Bulletin’s Shikha Rai, Bimal Dev BSE/NSE, and GPT Healthcare have contributed to the above report
Also Read